Turn Therapeutics (TTRX) Change in Cash (2024 - 2026)

Turn Therapeutics' Change in Cash history runs 3 years deep, the most recent figure standing at $6.1 million for Q1 2026.

• On a quarterly basis, Change in Cash rose 777.32% year-over-year to $6.1 million in Q1 2026; TTM through Mar 2026 was $8.9 million, a N/A change from a year earlier, with the FY2025 full-year figure at $4.2 million, up 1463.03% from the prior year.
• Change in Cash advanced to $6.1 million in Q1 2026 per TTRX's latest filing, from $2.0 million in the prior quarter.
• Across five years, Change in Cash topped out at $6.1 million in Q1 2026 and bottomed at $83819.0 in Q4 2024.
• The 3-year median for Change in Cash is $1.3 million (2025), against an average of $2.2 million.
• Across the five-year window, Change in Cash surged 2250.29% in 2025 and surged 777.32% in 2026, its largest moves.
• Year by year, Change in Cash stood at $83819.0 in 2024, then jumped by 2250.29% to $2.0 million in 2025, then soared by 211.75% to $6.1 million in 2026.
• Per Business Quant, the three latest TTRX Change in Cash figures stand at $6.1 million (Q1 2026), $2.0 million (Q4 2025), and $700034.0 (Q1 2025).